MTF Biologics:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MTF Biologics - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6568
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MTF Biologics(MTF) formerly known as Musculoskeletal Transplant Foundation, is a subsidiary of Donor Network West is a medical foundation that offers clinically sound and safe allograft tissue. The foundation offers allograft bone, sports tissue and dermal tissues. Its products include morselized allografts, spine and general orthopaedic tissue, spinal spacers, large segmental and reconstructive tissue, ligament reconstruction, meniscus and cartilage, biologics, scaffolds and fixation, acellular dermal allografts and cypropreserved split thickness skin grafts. MTF’s donor services division provides customized, need-based services to organ, tissue and eye recovery agencies through donor related education and support. The company has its presence in Pennsylvania, California and Germany MTF is headquartered in Edison, New Jersey, the US.

MTF Biologics – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MTF Biologics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MTF Biologics, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MTF Biologics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MTF Biologics, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
MTF Biologics, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MTF Biologics, Medical Equipment, Deal Details 11
Asset Purchase 11
Musculoskeletal Transplant Acquires Orthopedic Business From Cascade Medical Enterprises 11
Venture Financing 12
Bone Biologics Raises USD5.75 Million in Venture Financing 12
Partnerships 13
BoneSupport Receives Rights from MTF Biologics 13
Orthofix International Enters Into Co-Development Agreement With Musculoskeletal Transplant 14
Orthofix International Expands Co-Development Agreement With Musculoskeletal Transplant 15
Equity Offering 16
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of Shares 16
MTF Biologics – Key Competitors 18
MTF Biologics – Key Employees 19
MTF Biologics – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
Mar 02, 2017: MTF Announces New Recovery Partner Relationship — LifeLink 21
Mar 02, 2017: MTF Announces New Recovery Partner Relationship — New England Donor Services 22
Corporate Communications 23
Apr 10, 2018: MTF Biologics Appoints Joe Yaccarino President And CEO 23
Sep 21, 2017: Bruce Stroever to Retire from Musculoskeletal Transplant Foundation 24
Jun 13, 2017: MTF Announces Matthew Kuehnert, MD as New Medical Director 25
Feb 01, 2017: MTF appoints Joseph Roth to Board of Directors 26
Legal and Regulatory 27
Oct 02, 2017: Court Sets the Trial Date for MiMedx Patent Infringement Lawsuit Against MTF, Medline and Liventa 27
Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates 28
Government and Public Interest 29
Sep 25, 2018: The Plastic Surgery Foundation and MTF Biologics Open Applications for Allograft Tissue Research Grant Program 29
Product News 30
Mar 07, 2018: MTF Biologics and the University of Missouri Highlight Positive Clinical Results for Missouri Osteochondral Allograft Preservation System 30
Oct 03, 2017: World’s Largest Tissue Bank Rebrands to MTF Biologics 31
Other Significant Developments 32
Feb 06, 2018: MTF Biologics Distributes More Than 550,000 Tissue Grafts in 2017, Saving and Healing a Record Number of Lives 32
Oct 30, 2017: Plastic Surgery Foundation and MTF Biologics Partnership Funds Advances in Tissue Transplantation 33
Sep 28, 2017: DSM partners with the Musculoskeletal Transplant Foundation for distribution of regenerative materials and products 34
Jul 11, 2017: MTF Awards $1.74 Million in 2017 Extramural Research Grants 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
MTF Biologics, Medical Equipment, Key Facts 2
MTF Biologics, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MTF Biologics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MTF Biologics, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MTF Biologics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MTF Biologics, Deals By Market, 2012 to YTD 2018 9
MTF Biologics, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Musculoskeletal Transplant Acquires Orthopedic Business From Cascade Medical Enterprises 11
Bone Biologics Raises USD5.75 Million in Venture Financing 12
BoneSupport Receives Rights from MTF Biologics 13
Orthofix International Enters Into Co-Development Agreement With Musculoskeletal Transplant 14
Orthofix International Expands Co-Development Agreement With Musculoskeletal Transplant 15
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of Shares 16
MTF Biologics, Key Competitors 18
MTF Biologics, Key Employees 19
MTF Biologics, Other Locations 20

List of Figures
MTF Biologics, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MTF Biologics, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MTF Biologics, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MTF Biologics, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MTF Biologics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MTF Biologics, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
MTF Biologics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MTF Biologics, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[MTF Biologics:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • London North West Healthcare NHS Trust:企業の戦略的SWOT分析
    London North West Healthcare NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • AstraZeneca Plc (AZN):企業の財務・戦略的SWOT分析
    AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MAXONS Restorations Inc:企業の戦略的SWOT分析
    MAXONS Restorations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Bet Shemesh Engines Holdings (1997) Ltd:企業の戦略・SWOT・財務分析
    Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report Summary Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Gulfsands Petroleum plc (GPX):企業の財務・戦略的SWOT分析
    Summary Gulfsands Petroleum Plc (Gulfsands) is an oil and gas company that offers exploration, development, and production services. The company carries out acquisition, exploration, develops, and produces oil and natural gas. It holds interests in oil exploration and development projects in the Syr …
  • Oncology Venture ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB, is a developer of oncology products. The company offers products in the therapeutic areas of metastatic breast cancer, ovarian cancer, renal cancer, liver cancer, prostate cancer, multiple myeloma, and other …
  • GCL-Poly Energy Holdings Ltd (3800)-エネルギー分野:企業M&A・提携分析
    Summary GCL-Poly Energy Holdings Ltd. (GCL) is a provider of solar photovoltaic (PV) material and professional PV system solutions. The company produces and supplies high-quality solar grade and semiconductor grade polysilicon raw materials and silicon wafers to companies operating in the solar indu …
  • Emerson Electric Co (EMR):企業の財務・戦略的SWOT分析
    Emerson Electric Co (EMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Koncar – Elektroindustrija dd (KOEI-R-A):企業の財務・戦略的SWOT分析
    Summary Koncar - Elektroindustrija dd (Koncar) is an electrical equipment company that designs and develops power transmission, generation, distribution plants, and others. The company provides products such as electric vehicles, hydro power plant, accompanying equipment, electric traction plants, e …
  • Compagnie Financiere Richemont SA:企業の戦略・SWOT・財務情報
    Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • South African Express Airways (Pty) Ltd:企業の戦略・SWOT・財務分析
    South African Express Airways (Pty) Ltd - Strategy, SWOT and Corporate Finance Report Summary South African Express Airways (Pty) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Standard Insurance Co. Inc.:企業の戦略・SWOT・財務分析
    Standard Insurance Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary Standard Insurance Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Daiho Corporation
    Daiho Corporation - Strategy, SWOT and Corporate Finance Report Summary Daiho Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Atea ASA (ATEA):企業の財務・戦略的SWOT分析
    Atea ASA (ATEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • OceanaGold Corporation:企業の戦略・SWOT・財務情報
    OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report Summary OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • China North Industries Group Corp:企業の戦略的SWOT分析
    China North Industries Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • DURECT Corp (DRRX)-医療機器分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Weatherford International Plc (WFT):企業の財務・戦略的SWOT分析
    Weatherford International Plc (WFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Covalon Technologies Ltd (COV):企業の財務・戦略的SWOT分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercializer of medical products and healthcare technologies. The company offers advanced wound care, infection prevention and perioperative care products. Its wound care products include collagen matrix dressing, collagen m …
  • Medigen Biotechnology Corp (3176):企業の財務・戦略的SWOT分析
    Medigen Biotechnology Corp (3176) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆